# Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney Transplantation

> **NCT06057545** · PHASE3 · UNKNOWN · sponsor: **University Hospital, Essen** · enrollment: 30 (estimated)

## Conditions studied

- Pediatric Kidney Disease

## Interventions

- **DRUG:** Envarsus®
- **DRUG:** Prograf

## Key facts

- **NCT ID:** NCT06057545
- **Lead sponsor:** University Hospital, Essen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-25
- **Primary completion:** 2024-12
- **Final completion:** 2025-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06057545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06057545, "Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney Transplantation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06057545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*